UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Artificial tear therapy yields cost considerations: product type, angle of administration important factors, according to recent study

Ophthalmology times, 2007-08, Vol.32 (16), p.48

Hilton, Lisette

2007

Volltextzugriff (PDF)

Video

Ophthalmology times, 2015-08, Vol.40 (13), p.3

2015

Volltextzugriff (PDF)

Video

Ophthalmology times, 2015-08, Vol.40 (13), p.3

2015

Volltextzugriff (PDF)

Video

Ophthalmology times, 2015-08, Vol.40 (13), p.3

2015

Volltextzugriff (PDF)

Video

Ophthalmology times, 2015-08, Vol.40 (13), p.3

2015

Volltextzugriff (PDF)

Insert improves symptoms, quality of life for patients with dry eye, study finds: hydroxypropyl cellulose material allows for continuous coating of ocular surface

Ophthalmology times, 2009-07, Vol.34 (14), p.26

Petrou, Ilya

2009

Volltextzugriff (PDF)

Combination agents target early, late stages of allergy: antihistamine plus mast cell, eosinophil inhibition makes ophthalmic drops effective year-round

Ophthalmology times, 2003-05, Vol.28 (9), p.20

Groves, Nancy

2003

Volltextzugriff (PDF)

Combo agent alters cataract regimen: phenylephrine 1%/ketorolac 0.3% injection enhances outcomes; improves intra- and postoperative patient comfort

Ophthalmology times, 2015-07, p.10

Krader, Cheryl Guttman

2015

Volltextzugriff (PDF)

Device helps monitor patient eye drop regimen, adherence: video imaging feature captures medication instillation technique in clinic, at-home settings

Ophthalmology times, 2015-03, p.8

Charters, Lynda

2015

Volltextzugriff (PDF)

Novel tear therapy a new OTC option for relief of dry eye symptoms: electrostatic reaction between product, ocular surface likely plays substantial role

Ophthalmology times, 2015-02, p.25

McDonald, Marguerite B

2015

Volltextzugriff (PDF)

Tailor treatment for dry eye: individualized therapy is paramount for different levels, degrees, variable responses

Ophthalmology times, 2012-05, Vol.37 (9), p.14

Charters, Lynda

2012

Volltextzugriff (PDF)

Vehicle enables better dosing: improved pharmacokinetics: twice-daily moxifloxacin formulation brings enhanced bioavailability, greater convenience

Ophthalmology times, 2011-09, Vol.36 (18), p.27

Krader, Cheryl Guttman

2011

Volltextzugriff (PDF)

Concomitant use of tear products with cyclosporine assessed: both drops had similar objective measures; one showed improvement in subjective evaluations

Ophthalmology times, 2010-02, Vol.35 (4), p.34

Groves, Nancy

2010

Volltextzugriff (PDF)

Bepotastine solution shown to, be effective against allergic conjunctivitis in research: drop also decreases nasal symptoms related to ocular allergies, according to physician

Ophthalmology times, 2009-02, Vol.34 (4), p.17

Groves, Nancy

2009

Volltextzugriff (PDF)

Distinguish formulations for patients: differential diagnosis crucial to identify dry eye, administer treatment

Ophthalmology times, 2009-02, Vol.34 (4), p.14

2009

Volltextzugriff (PDF)

Ketotifen drop designed to provide ocular itching relief: over-the-counter ophthalmic solution treats episodic, seasonal, and perennial disease

Ophthalmology times, 2008-11, Vol.33 (21), p.23

Bowers, Lois A

2008

Volltextzugriff (PDF)

Adding artificial tear to regimen may boost effectiveness of cyclosporine A: combination therapy: potential treatments on horizon include new anti-inflammatories, androgens, secretagogues

Ophthalmology times, 2008-07, Vol.33 (14), p.24

Bowers, Lois A

2008

Volltextzugriff (PDF)

Once-daily bromfenac safe, effective postoperatively: new formulation successfully manages post-surgical inflammation and pain, studies show

Ophthalmology times, 2008-06, Vol.33 (11), p.22

Rajecki, Ron

2008

Volltextzugriff (PDF)

Eye drops restore and maintain ocular surface health: product provides balance of extended dwell time, minimal blur after instillation

Ophthalmology times, 2008-05, Vol.33 (9), p.22

Guttman, Cheryl

2008

Volltextzugriff (PDF)

Effects of dry eye therapy continue after treatment stopped: drops lead to persistent beneficial effect on the ocular surface, according to researchers

Ophthalmology times, 2006-08, Vol.31 (16), p.18

Charters, Lynda

2006

Volltextzugriff (PDF)

Sustained drug delivery may transform glaucoma: advances could make administering medications to eye easier, while enhancing adherence

Ophthalmology times, 2013-10, Vol.38 (19), p.14

Gebhart, Fred

2013

Volltextzugriff (PDF)

Reducing the need for postoperative eye drops: protocol addresses adherence, financial impact among large numbers of patients

Ophthalmology times, 2013-10, Vol.38 (19), p.16

Gills, James P

2013

Volltextzugriff (PDF)

More concentrated formulation provides allergy relief with once-daily dosing; study showed effective relief of ocular signs, symptoms of allergic conjunctivitis

Ophthalmology times, 2004-05, Vol.29 (10), p.14

Guttman, Cheryl

2004

Volltextzugriff (PDF)

Small drop delivers big advancement: Novel smart device microdoses the eye to precisely target total exposure to drops

Ophthalmology times, 2018-08, Vol.43 (13), p.30

Ianchulev, Sean

2018

Volltextzugriff (PDF)

Dry eye sufferers may now consider LASIK procedure: treating the root cause with topical cyclosporine drops allows for safe, effective surgery

Ophthalmology times, 2003-12, Vol.28 (23), p.19

Guttman, Cheryl

2003

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

ThemaAdministration, Topical

ThemaHumans

Zeitschrift / SerieOphthalmology Times

ThemaOphthalmic Solutions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(32)

Publikationsform

magazinearticle
(32)

Sprache

Englisch
(32)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Artificial tear therapy yields cost considerations: product type, angle of administration important factors, according to recent study

Video

Video

Video

Video

Insert improves symptoms, quality of life for patients with dry eye, study finds: hydroxypropyl cellulose material allows for continuous coating of ocular surface

Combination agents target early, late stages of allergy: antihistamine plus mast cell, eosinophil inhibition makes ophthalmic drops effective year-round

Combo agent alters cataract regimen: phenylephrine 1%/ketorolac 0.3% injection enhances outcomes; improves intra- and postoperative patient comfort

Device helps monitor patient eye drop regimen, adherence: video imaging feature captures medication instillation technique in clinic, at-home settings

Novel tear therapy a new OTC option for relief of dry eye symptoms: electrostatic reaction between product, ocular surface likely plays substantial role

Tailor treatment for dry eye: individualized therapy is paramount for different levels, degrees, variable responses

Vehicle enables better dosing: improved pharmacokinetics: twice-daily moxifloxacin formulation brings enhanced bioavailability, greater convenience

Concomitant use of tear products with cyclosporine assessed: both drops had similar objective measures; one showed improvement in subjective evaluations

Bepotastine solution shown to, be effective against allergic conjunctivitis in research: drop also decreases nasal symptoms related to ocular allergies, according to physician

Distinguish formulations for patients: differential diagnosis crucial to identify dry eye, administer treatment

Ketotifen drop designed to provide ocular itching relief: over-the-counter ophthalmic solution treats episodic, seasonal, and perennial disease

Adding artificial tear to regimen may boost effectiveness of cyclosporine A: combination therapy: potential treatments on horizon include new anti-inflammatories, androgens, secretagogues

Once-daily bromfenac safe, effective postoperatively: new formulation successfully manages post-surgical inflammation and pain, studies show

Eye drops restore and maintain ocular surface health: product provides balance of extended dwell time, minimal blur after instillation

Effects of dry eye therapy continue after treatment stopped: drops lead to persistent beneficial effect on the ocular surface, according to researchers

Sustained drug delivery may transform glaucoma: advances could make administering medications to eye easier, while enhancing adherence

Reducing the need for postoperative eye drops: protocol addresses adherence, financial impact among large numbers of patients

More concentrated formulation provides allergy relief with once-daily dosing; study showed effective relief of ocular signs, symptoms of allergic conjunctivitis

Small drop delivers big advancement: Novel smart device microdoses the eye to precisely target total exposure to drops

Dry eye sufferers may now consider LASIK procedure: treating the root cause with topical cyclosporine drops allows for safe, effective surgery

Aktive Filter

Suchergebnisse filtern